BioCrossroads

Name

BioCrossroads

Legal name

BioCrossroads

Website

https://biocrossroads.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales

Revenue model

1. Ecosystem Catalyst Services: BioCrossroads operates as a non-profit initiative under the Central Indiana Corporate Partnership (CICP), advancing Indiana's life sciences sector through market research, investment facilitation, startup support, workforce development, and industry convenings. Revenue is generated through sponsor partnerships, event fees, and government/corporate support rather than product sales.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

BioCrossroads is a non-profit catalyst organization that advances Indiana's life sciences sector by convening industry, academic, and government stakeholders; producing market research and data dashboards; managing early-stage venture capital funds (Indiana Seed Funds I, II, III totaling ~$24M AUM and Crossroads Health Ventures at $21M+); and running startup mentorship, founder community, and workforce development programs. Its offerings — events, mentorship, funds, reports, and apprenticeships — are delivered free of charge to the Indiana life sciences ecosystem.

Product overview

BioCrossroads is a catalyst organization for Indiana's life sciences industry that operates a portfolio of interconnected programs rather than a single unified software product. Its offerings include: annual events (BioCrossroads Life Sciences Summit, FrameWORX educational series); talent development programs (AXIS Mentoring Program, Odyssey Group founder community, Career Hub, CareerTraX video library, INCAP workforce apprenticeship); capital investment vehicles (Indiana Seed Fund series, Crossroads Health Ventures fund); data resources (Life Sciences Dashboard, Book of Data and Organizations); and the Startup Hub for entrepreneurs. The organization also manages the August M. Watanabe Life Sciences Champion of the Year Award and produces the BioSignals Podcast. These programs work together to advance collaboration, expertise, and investments that fuel innovation across Indiana's $102 billion life sciences ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• Indiana Seed Funds: Early-stage life sciences focused investment funds managed by BioCrossroads
• Crossroads Health Ventures
• AXIS Mentoring Program
• Odyssey Group
• BioCrossroads Life Sciences Summit
• FrameWORX
• BioSignals Podcast
• CareerTraX
• Indiana Career Apprenticeship Pathway (INCAP)
• Book of Data and Organizations
• Life Sciences Dashboard
• Radiopharmaceutical Capital of the World™

Products and services

• BioCrossroads Life Sciences Summit Premier annual event for Indiana's life sciences sector, convening 250+ leaders from academia, finance, government, industry, and philanthropy to discuss the latest trends, research, and innovations. The 2026 Summit theme is 'Empowering Indiana's Innovation Engine: Harnessing AI for Life Sciences Advancement.'
• FrameWORX Educational Series Dynamic educational series providing a platform for engaging thought leaders, offering unique viewpoints, and fostering enhanced collaboration among Indiana's research institutions, philanthropic organizations, and enterprises. Includes programs on radiopharmaceuticals, medical devices, cancer care innovation, and workforce development.
• AXIS Mentoring Program Mentoring program focusing on developing and nurturing entrepreneurial talent within Indiana's life sciences sector, modeled after MIT's Venture Mentoring Service. Connects experienced mentors with promising entrepreneurs through team-based mentoring.
• Odyssey Group Founder community for Indiana life sciences providing real conversations, practical tools, and direct access to biotech industry leaders in finance, strategy, and business development. Convenes events throughout the year.
• Career Hub Comprehensive gateway to career exploration tools and information about local and national life sciences initiatives, helping jumpstart careers in STEM and life sciences. Includes the CareerTraX video library and INCAP programs.
• CareerTraX Dynamic video resource showcasing career opportunities in Indiana's life sciences industry through interviews, facility tours, and expert advice across fields like biotechnology, pharmaceutical manufacturing, nuclear medicine, and data science.
• Indiana Career Apprenticeship Pathway (INCAP) Professional education and training pathway combining classroom education with on-the-job training to prepare high school students and adults for life sciences careers, including the INCAP Apprenticeship Program and INCAP Career Program.
• Indiana Seed Fund Early-stage venture capital fund series (Fund I, II, III) investing in biotechnology, pharmaceutical, medical device, diagnostics, ag-biotech, and health information technology products and platforms. 30 portfolio companies have raised more than $796 million in follow-on venture investment.
• Crossroads Health Ventures Early-stage venture fund supporting Indiana-based life sciences startups, backed by Eli Lilly, Corteva, Elanco, Indiana University, Parkview Health, and the Indiana Economic Development Corp. Targets 15-20 early-stage companies.
• Life Sciences Dashboard Interactive dashboard providing key insights on workforce, innovation, and economic impact data shaping Indiana's life sciences sector.
• Book of Data and Organizations Comprehensive guide chronicling health data, capabilities, and talent assets across Indiana's industry, government, health systems, academia, and digital health startups.
• Startup Hub Step-by-step guide navigating the startup journey from idea to formation, funding, mentorship, and growth with Indiana-specific resources and partners for biotech, medtech, and health tech innovators.
• BioSignals Podcast The BioCrossroads Podcast featuring conversations with leaders shaping Indiana's life sciences sector across biopharma breakthroughs, medical device innovation, workforce strategy, and economic development. Available on Apple, Spotify, and Amazon Music.

Quantifiable outcome

• 30 portfolio companies have raised more than $796 million in additional venture capital following BioCrossroads seed fund investments.
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

23 partnerships are on record, tiered core, major and minor.

• Central Indiana Corporate Partnership (CICP)coreStrategic or Co-development PartnerBioCrossroads is an initiative of CICP, formed in 1999 to bring together Central Indiana's prominent corporations, foundations, and universities for collaborative economic development. CICP sponsors five sector initiatives including BioCrossroads, AgriNovus, Ascend, Conexus, and TechPoint. BioCrossroads provides ecosystem leadership for the life sciences sector within this umbrella.
• Indiana UniversitycoreStrategic or Co-development PartnerMajor research partner and co-backer of the Indiana Seed Funds. IU School of Medicine is a hub for neuroscience and Alzheimer's research. IU co-founded the Indiana Biosciences Research Institute. IU Innovation Office supports the AXIS mentoring program. Co-investor in Crossroads Health Ventures ($21M fund).
• Purdue UniversitycoreStrategic or Co-development PartnerMajor research partner with strengths in engineering, pharmaceutical sciences, and agricultural biosciences. Purdue's Innovation Office supports the AXIS mentoring program. Key partner in the One Health Innovation District and the William D. and Sherry L. Young Advanced Manufacturing of Pharmaceuticals Institute.
• University of Notre DamecoreStrategic or Co-development PartnerOne of three R1 research universities supporting Indiana's life sciences ecosystem. Notre Dame's Innovation Office supports the AXIS mentoring program and the William D. and Sherry L. Young Advanced Manufacturing of Pharmaceuticals Institute. Dr. Jeff Rhoads serves on the BioCrossroads Board of Directors.
• Indiana Biosciences Research Institute (IBRI)majorStrategic or Co-development PartnerThe first industry-inspired research institute in the nation, founded by global life science companies with a mission to accelerate discoveries for metabolic disease and poor nutrition. BioCrossroads helped launch IBRI and it operates as a key ecosystem organization. Alan Palkowitz serves on the BioCrossroads Board.
• Indiana Health Information Exchange (IHIE)majorStrategic or Co-development PartnerBioCrossroads helped launch IHIE, which operates the nation's largest health information exchange, connecting 100+ hospitals, care facilities, health clinics, and healthcare providers. A key data and interoperability asset for the ecosystem.
• OrthoWorxmajorStrategic or Co-development PartnerCommunity-based initiative advancing the orthopedic industry in Warsaw, Indiana (the Orthopedic Capital of the World®). Founded in 2009 with initial funding from Lilly Endowment. BioCrossroads helped establish OrthoWorx as part of its ecosystem-building activities.
• Datalys CenterminorStrategic or Co-development PartnerA 501(c)(3) non-profit specializing in research programs focused on the health and safety of athletes and physically active populations. BioCrossroads helped establish Datalys Center as part of its ecosystem-building activities.
• NovartismajorStrategic or Co-development PartnerSwitzerland-headquartered pharmaceutical company constructing a new radioligand therapy (RLT) manufacturing facility in Indianapolis, extending its world-class manufacturing and supply chain capabilities. Anchors Indiana's position as the Radiopharmaceutical Capital of the World™.
• POINT BiopharmamajorStrategic or Co-development PartnerMajor radiopharmaceutical company operating in Indiana. Anchors the growing radiopharmaceutical ecosystem alongside Novartis and Isotopia Molecular Imaging, strengthening Indiana's claim as the Radiopharmaceutical Capital of the World™.
• Cardinal HealthmajorStrategic or Co-development PartnerExpanded its theranostics facility in Indianapolis with a $50+ million investment to accelerate production of cancer-fighting radiopharmaceuticals. Major manufacturing and logistics anchor in Indiana's radiopharmaceutical sector.
• Isotopia Molecular ImagingmajorStrategic or Co-development PartnerRadiopharmaceutical company operating in Indiana as part of the growing isotope production and targeted radiotherapy ecosystem. Partner in the Radiopharmaceutical Capital of the World™ ecosystem.
• SpectronRxminorStrategic or Co-development PartnerRadiopharmaceutical company experiencing continued growth in Indiana, scaling talent, technology, and treatments worldwide. Highlighted as a success story in Indiana's radiopharma ecosystem.
• 16 Tech Innovation DistrictcoreStrategic or Co-development Partner50-acre innovation community in downtown Indianapolis where BioCrossroads and CICP are co-located. 16 Tech brings together research, industry, and entrepreneurial organizations in a shared innovation campus. Supports the AXIS mentoring program as a partner.
• Cook MedicalcoreStrategic or Co-development PartnerWorld's largest privately-held medical company, headquartered in Bloomington, Indiana. Founded over 50 years ago by Bill Cook. Dan Peterson, VP of Industry & Government Affairs at Cook Medical, serves as Chairman of the BioCrossroads Board of Directors.
• Zimmer BiometcoreStrategic or Co-development PartnerMajor global medical device company operating in Indiana's orthopedic hub. Kirk Bailey, VP of Research & Engineering at Zimmer Biomet, serves on the BioCrossroads Board of Directors. Key partner in the Northeast Indiana orthopedic ecosystem.
• RochemajorStrategic or Co-development PartnerGlobal pharmaceutical and diagnostics company with significant Indiana presence (including predecessor company Bio-Dynamics founded by Bill Eason, Watanabe Award recipient). Ron DiNizo, VP of Corporate Accounts at Roche, serves on the BioCrossroads Board of Directors.
• Indiana UniversitycoreTechnology or IntegrationIU hosted NVIDIA co-founder Chris Malachowsky in May 2026 to showcase AI research infrastructure and bioscience capabilities. IU's $800 million biosciences and AI investments since 2023 include a $40 million collaboration with Eli Lilly on Alzheimer's research and the Big Red 200 supercomputer supporting 500+ AI research projects powered by NVIDIA technology. IU is a key partner in the IU Launch Accelerator for Biosciences.
• Indiana State GovernmentcoreStrategic or Co-development PartnerGovernor Mike Braun committed $1 billion over 10 years to accelerate life sciences growth with a goal of creating 100,000 jobs. Indiana's Secretary of Commerce participates in ecosystem convenings. The state has been designated a federal Tech Hub for biomanufacturing.
• National Institute for Biopharmaceutical Manufacturing (NIBRT)majorStrategic or Co-development PartnerInternational biopharmaceutical manufacturing training organization in formal partnership with Indiana's Applied Research Institute to boost Indiana's biomanufacturing workforce development. Announced at the 2025 Life Sciences Summit.
• Cooley LLPminorStrategic or Co-development PartnerGlobal law firm supporting the Odyssey Group founder community with practical founder tools and resources including the Biotech Startup Workshop Deck and NewCo Setup Tasks Checklist.
• JP MorganminorStrategic or Co-development PartnerFinancial services firm supporting the Odyssey Group founder community as a sponsor, providing expertise in finance and business development for biotech founders.
• TEConomy PartnersmajorStrategic or Co-development PartnerGlobal research and analysis firm that collaborated with BioCrossroads to develop the 10-year Strategic Framework for Advancing Indiana's Life Sciences Industry. Authors of biennial bioscience development reports used for strategic planning.

Scale indicators16 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@BioCrossroads/featured
• LinkedInlinkedin.com/company/biocrossroads
• Xx.com/BioCrossroads

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments24 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioCrossroads